Document is current
Any future updates will be listed below
-
Authors
Ghasemi, Ali
Martinez-Usatorre, Amaia https://orcid.org/0000-0002-3416-1529
Liu, Yang
Demagny, Hadrien
Li, Luqing
Mohammadzadeh, Yahya
Hurtado, Andreas
Hicham, Mehdi
Henneman, Linda
Pritchard, Colin E. J. https://orcid.org/0000-0001-7848-9377
Speiser, Daniel E. https://orcid.org/0000-0003-2031-3250
Migliorini, Denis https://orcid.org/0000-0003-0151-3222
De Palma, Michele https://orcid.org/0000-0001-9128-5459
- License Information
-
More Information
Article History
Received: 2 October 2024
Accepted: 28 August 2025
First Online: 15 October 2025
Competing interests
: M.D.P. has received sponsored research grants from EVIR Therapeutics, Hoffmann La-Roche and Deciphera Pharmaceuticals, serves on the Scientific Advisory Boards of EVIR Therapeutics, Montis Biosciences, Macomics, Deciphera Pharmaceuticals, Light Chain Bioscience/Novimmune, and Genenta. M.D.P., A.G., Y.M. and A.M.-U. are inventors on patents WO/2017/134100, WO/2023/232777, and application No. 24211693.7 filed by EPFL, which cover methods for DC engineering. D.E.S. serves on the Scientific Advisory Board of EVIR Therapeutics. D.M. is a consultant for Limula and MPC Therapeutics, scientific co-founder of Cellula Therapeutics, and inventor on unrelated patents filed by the University of Pennsylvania, Istituto Oncologico della Svizzera Italiana (IOSI) and the University of Geneva. The other authors declare no Competing interests.
